Heron Therapeutics | HRTX - 市值



金融业
股票价格
USD
资产
USD 252.26M
现金及等价物
USD 20.72M
销售成本
USD 11.12M
流动资产
USD 229.85M
流动负债
USD 92.15M
债务
USD 149.65M
股息收益率
0
EBIT
USD 38K
EBITDA
USD -3.88M
员工
126
EPS每股收益
USD -0.02
股本和储备
USD 6.91M
销售毛利
USD 29.47M
债务利息支出
USD 600K
利息收入
USD 433K
贷款资金
USD 140.64M
市值
USD 51.7M
净收入
USD -2.95M
营业费用
USD 40.55M
营业利润
USD 38K
普通股股本
USD 188.31M
税前利润
USD -2.95M
销售收入
USD 40.59M
销售和管理费用
USD 23.74M
股票
USD 54.57M
贸易债权人
USD 11.64M
应收帐款人
USD 89.59M


市值 更改 日
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.88B 133M 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
Eisai JPY 1.2T 219.32B 2026-06
Emergent BioSolutions USD 125M 51M 2023-12
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 23.11B 12.19B 2026-06
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pacira USD 998M 83M 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Veracyte USD 4.69B 2.12B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06